- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02302638
Embryo Development Using Two Commercial Single-step Media
June 8, 2015 updated by: Eugonia
Embryo Development and Utilization Using Two Commercial Single-step Media
This prospective study with sibling oocytes will evaluate the efficiency of two commercial single-step media, namely Sage 1-step and Continuous Single Culture Medium (CSCM), in terms of embryo utilization rates, blastocyst formation rates, embryo quality and pregnancy rates.
Embryos will be cultured continuously for up to 6 days under identical conditions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
43
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Attica
-
Athens, Attica, Greece, 11528
- Eugonia Assisted Reproduction Unit
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- at least 10 oocytes retrieved
Exclusion Criteria:
- frozen oocytes
- testicular biopsy
- less than 10 oocytes retrieved
- older than 40 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Sage 1-step
Embryo culture in different single-step media: Half of each patient's oocytes will be randomly allocated to be cultured in Sage 1-step medium for up to six days following oocyte retrieval. |
Half of each patient's oocytes will be randomly allocated to be cultured either in Sage 1-step medium (Origio) or in CSC medium (Irvine Scientific) for up to six days following oocyte retrieval.
|
|
Active Comparator: CSCM
Embryo culture in different single-step media: Half of each patient's oocytes will be randomly allocated to be cultured in CSC medium for up to six days following oocyte retrieval. |
Half of each patient's oocytes will be randomly allocated to be cultured either in Sage 1-step medium (Origio) or in CSC medium (Irvine Scientific) for up to six days following oocyte retrieval.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Utilization rates
Time Frame: 6 days post oocyte retrieval
|
Utilization = embryos selected for transfer and cryopreservation
|
6 days post oocyte retrieval
|
|
Blastocyst formation
Time Frame: 5 days post oocyte retrieval
|
Number of blastocysts on day 5 post oocyte retrieval per fertilized oocytes
|
5 days post oocyte retrieval
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Embryo quality on day 3
Time Frame: 3 days post oocyte retrieval
|
3 days post oocyte retrieval
|
|
|
blastocyst quality on day 5
Time Frame: 5 days post oocyte retrieval
|
5 days post oocyte retrieval
|
|
|
positive pregnancy test
Time Frame: 15 days post oocyte retrieval
|
15 days post oocyte retrieval
|
|
|
clinical pregnancy
Time Frame: 7 weeks of gestation
|
presence of gestational sac with positive fetal heartbeat
|
7 weeks of gestation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ioannis A Sfontouris, PhD, Eugonia
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
June 1, 2015
Study Registration Dates
First Submitted
November 25, 2014
First Submitted That Met QC Criteria
November 26, 2014
First Posted (Estimate)
November 27, 2014
Study Record Updates
Last Update Posted (Estimate)
June 9, 2015
Last Update Submitted That Met QC Criteria
June 8, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Sage vs CSCM
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
-
Medipol UniversityNot yet recruitingMale Infertility | Unexplained Infertility | Sperm DNA Fragmentation
Clinical Trials on embryo culture in different single-step media
-
Weill Medical College of Cornell UniversityVitrolifeTerminatedInfertilityUnited States
-
VitrolifeCompletedInfertilityUnited States, Sweden
-
ART Fertility Clinics LLCRecruiting
-
Ganin Fertility CenterUnknownInfertility | Mosaicism | Aneuploidy RateEgypt
-
University Hospital, BordeauxProgramme Hospitalier de Recherche Clinique Inter-Régionale (PHRC-I)Active, not recruiting
-
The First Affiliated Hospital with Nanjing Medical...RecruitingFertility Issues | Embryo Culture | Blastocyst IVFChina
-
Istituto Ortopedico GaleazziUnknownAssessment of the Trophic and Anti-inflammatory Effect of SVF Added With HPL
-
Anecova SATerminatedInfertility | Reproductive SterilitySpain
-
Mansoura Integrated Fertility CenterRahem Fertility CenterCompleted
-
Shaare Zedek Medical CenterCompletedUrinary Tract Infection